Table 3.
Treatment | Dose (mg/kg) | Initial footpad thickness (mm) | After 4 h |
After 24 h |
After 48 h |
|||
---|---|---|---|---|---|---|---|---|
Footpad thickness (mm) | Percentage increase (%) | Footpad thickness (mm) | Percentage increase (%) | Footpad thickness (mm) | Percentage increase (%) | |||
Nanocurc | 5 | 2.21 ± 0.04a | 3.26 ± 0.07a | 48.0 | 2.78 ± 0.10a | 26.0 | 2.60 ± 0.03a | 18.0 |
Nanocurc | 10 | 2.20 ± 0.04a | 3.56 ± 0.05a | 62.0 | 2.99 ± 0.10a | 36.0 | 2.58 ± 0.09a | 17.0 |
Free-curc | 5 | 2.18 ± 0.05a | 3.58 ± 0.22a | 65.0 | 2.90 ± 0.09a | 34.0 | 2.61 ± 0.01a | 20.0 |
Free-curc | 10 | 2.26 ± 0.04a | 3.13 ± 0.06a | 39.0 | 2.96 ± 0.07a | 31.0 | 2.70 ± 0.11a | 19.0 |
Control | – | 2.23 ± 0.04a | 3.01 ± 0.07a | 35.0 | 2.69 ± 0.06a | 20.0 | 2.66 ± 0.01a | 19.0 |
Nanocurc, nanocurcumin; Free-curc, free curcumin. Similar superscripts denote no significant difference (p > 0.05) while different superscripts denote significant difference (p < 0.05).